131220.Kq
The company operates in the healthcare services and equipment industry, specializing in medical equipment, supplies, and distribution, generating revenue primarily through the sale and provision of medical products and services.
Business. The company operates in the healthcare services and equipment industry, specializing in medical equipment, supplies, and distribution, generating revenue primarily through the sale and provision of medical products and services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, specializing in medical equipment, supplies, and distribution, generating revenue primarily through the sale and provision of medical products and services.
The company maintains a strong liquidity position, with a current ratio of 3.68, indicating a robust ability to meet short-term obligations. Its cash and equivalents amount to 4,924,425,230 KRW, and free cash flow stands at 5,574,240,790 KRW, supporting operational flexibility and potential reinvestment. The price-to-book ratio of 0.67 suggests the company is trading at a discount relative to its book value, which may reflect market skepticism or undervaluation.
Profitability metrics show a return on equity of 7.3% and a return on assets of 4.54%, which are below the typical thresholds for high-performing healthcare firms. The operating margin, calculated as operating income of 5,530,676,720 KRW on revenue of 81,117,767,870 KRW, yields a margin of approximately 6.8%, which is in line with industry norms but leaves room for improvement.
The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic breakdown provided. This lack of diversification may expose the company to sector-specific risks, particularly in the volatile healthcare equipment and services market.
Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant revenue deltas expected in the current or next fiscal year. Historical revenue growth has been modest, and the absence of aggressive capital expenditure plans suggests a conservative approach to expansion.
Risk factors remain low, with no immediate liquidity or dilution concerns identified. The debt-to-equity ratio of 0.01 indicates minimal leverage, reducing financial risk. However, the company's reliance on a single business model and the absence of a detailed geographic breakdown may limit visibility into potential regional vulnerabilities.
Recent filings and transcripts have not revealed any material events or strategic shifts. The company appears to be operating within a stable financial and operational framework, with no significant changes in its business model or risk profile in the latest disclosures.
- The company maintains a strong liquidity position with a current ratio of 3.68 and significant free cash flow.
- Profitability metrics are in line with industry norms but suggest room for improvement in return on equity and operating margins.
- The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- Growth projections are stable, with no significant revenue deltas expected in the near term.
- Risk factors are low, with minimal leverage and no immediate liquidity or dilution concerns.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 131220.KQ Market data — financials · 2026-05-26